Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview

NEXT STORY
Helix BioPharma Corp. Closes Second Tranche of Private Placement
PREV STORY
G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Announces Presentations at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Phase 2a Trial of RX-5902 Advances to Stage 2 Based on Encouraging Progression Free ...

author_avatar
NASDAQ Market News

Quipt Home Medical Announces Date and Time for Q2 Fiscal 2021 Quarterly Conference Call and Audio Webcast

author_avatar
NASDAQ Market News

North America In-Vitro Diagnostics Market 2019-2025 – Growing Significance of Companion Diagnostics & Increasing Number of Strategic Deals

author_avatar
NASDAQ Market News